BOOTHBAY FUND MANAGEMENT, LLC - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 83 filers reported holding OVID THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$224,000
-2.2%
71,4890.0%0.01%0.0%
Q4 2021$229,000
-39.1%
71,489
-36.2%
0.01%
-50.0%
Q3 2021$376,000
-32.0%
112,044
-20.8%
0.01%
-44.4%
Q2 2021$553,000
+4.3%
141,433
+7.3%
0.02%
-10.0%
Q1 2021$530,000
+204.6%
131,834
+125.9%
0.02%
+42.9%
Q1 2020$174,000
-44.6%
58,368
-22.9%
0.01%
-48.1%
Q4 2019$314,000
+22.2%
75,738
-4.6%
0.03%
+12.5%
Q3 2019$257,00079,3950.02%
Other shareholders
OVID THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders